Xtx Topco LTD Oramed Pharmaceuticals Inc. Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 24,716 shares of ORMP stock, worth $57,341. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,716
Previous 15,474
59.73%
Holding current value
$57,341
Previous $39,000
53.85%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ORMP
# of Institutions
62Shares Held
7.42MCall Options Held
4KPut Options Held
2.1K-
Bml Capital Management, LLC Zionsville, IN2.19MShares$5.07 Million3.14% of portfolio
-
Murchinson Ltd. Toronto, A61.71MShares$3.96 Million1.22% of portfolio
-
Boothbay Fund Management, LLC New York, NY828KShares$1.92 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$850,0502.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$672,3420.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $90.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...